Please assess the completion status of the following clinical trial:

Trial Title: Insulin Detemir Action in Cerebro

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetic patients;~* Diabetes duration =/\> 1 year;~* HbA1c \~ 7,5%;~Exclusion Criteria:~* Recent onset of DM;~* BMI \< 18 OR \> 35 kg/m2;~* T2DM;~* History of major heart/renal disease;~* Severe untreated proliferative retinopathy;~* History of recurrent severe hypoglycaemia;~* (History of) brain disorders;~* Alcohol abuse,(History of) drug abuse, benzodiazepines, selective beta-blockers, oral steroids, oral anticoagulants;~* Current psychiatric disease/treatment;~* (history of) eating disorders;~* History of severe head trauma accompanied by loss of consciousness;~* Any endocrine disease not well controlled for at least 3 months;~* Inability to undergo MRI;~* Visual acuity \< 0.3;~* Known or suspected allergy to trial product or related products

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).